Abstract

Endogenous cyclic diadenylate phosphodiesterase activity was accidentally detected in lysates of Escherichia coli BL21. Since this kind of activity is uncommon in Gram-negative bacteria, its identification was undertaken. After partial purification and analysis by denaturing gel electrophoresis, renatured activity correlated with a protein identified by fingerprinting as CpdB (cpdB gene product), which is annotated as 3´-nucleotidase / 2´,3´-cyclic-mononucleotide phosphodiesterase, and it is synthesized as a precursor protein with a signal sequence removable upon export to the periplasm. It has never been studied as a recombinant protein. The coding sequence of mature CpdB was cloned and expressed as a GST fusion protein. The study of the purified recombinant protein, separated from GST, confirmed CpdB annotation. The assay of catalytic efficiencies (kcat/Km) for a large substrate set revealed novel CpdB features, including very high efficiencies for 3´-AMP and 2´,3´-cyclic mononucleotides, and previously unknown activities on cyclic and linear dinucleotides. The catalytic efficiencies of the latter activities, though low in relative terms when compared to the major ones, are far from negligible. Actually, they are perfectly comparable to those of the ‘average’ enzyme and the known, bona fide cyclic dinucleotide phosphodiesterases. On the other hand, CpdB differs from these enzymes in its extracytoplasmic location and in the absence of EAL, HD and DHH domains. Instead, it contains the domains of the 5´-nucleotidase family pertaining to the metallophosphoesterase superfamily, although CpdB lacks 5´-nucleotidase activity. The possibility that the extracytoplasmic activity of CpdB on cyclic dinucleotides could have physiological meaning is discussed.

Highlights

  • The cpdB gene is widespread among prokaryotes, most studies are focused on Gramnegative bacteria

  • E. coli cpdB mutants are devoid of the 3 ́-nucleotidase and 2 ́,3 ́-cyclic-nucleotide phosphodiesterase activities previously studied in bacterial extracts [2, 3]

  • A soluble lysate of nontransformed E. coli BL21 cells was fractionated by gel filtration and ionexchange chromatography, what yielded a partially purified preparation enriched in c-di-AMP phosphodiesterase activity (Fig 1)

Read more

Summary

Introduction

The cpdB gene is widespread among prokaryotes, most studies are focused on Gramnegative bacteria. E. coli cpdB mutants are devoid of the 3 ́-nucleotidase and 2 ́,3 ́-cyclic-nucleotide phosphodiesterase activities previously studied in bacterial extracts [2, 3]. This defect is complemented by transformation with DNA fragments containing the cpdB gene [1]. The homologous gene of Yersinia enterocolitica has been cloned and cpdB mutants are unable to grow on 2 ́,3 ́-cAMP as the only carbon source, defect complemented by transformation with cpdB [4]. Despite the availability of this information on cpdB, the annotation of the genes and their protein products (CpdB) as 3 ́-nucleotidase / 2 ́,3 ́-cyclic-nucleotide phosphodiesterase relies just on the absence of these activities in cpdB mutant bacteria, or just on sequential homology. The cpdB gene has been studied previously, to our knowledge, the CpdB protein has not been expressed and characterized enzymatically as a recombinant protein

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call